Litcius/Paper detail

Cyanobacterial metabolites as promising drug leads against the M <sup>pro</sup> and PL <sup>pro</sup> of SARS-CoV-2: an <i>in silico</i> analysis

Devashan Naidoo, Ayan Roy, Pallab Kar, Taurai Mutanda, Akash Anandraj

2020Journal of Biomolecular Structure and Dynamics47 citationsDOIOpen Access PDF

Abstract

and pave the foundation for the development of novel effective therapeutics against COVID-19.Communicated by Ramaswamy H. Sarma.

Topics & Concepts

In silicoProteasesProteaseBiologyDepsipeptideVirologyComputational biologyPharmacologyChemistryBiochemistryEnzymeGeneComputational Drug Discovery MethodsAlgal biology and biofuel productionMalaria Research and Control
Cyanobacterial metabolites as promising drug leads against the M <sup>pro</sup> and PL <sup>pro</sup> of SARS-CoV-2: an <i>in silico</i> analysis | Litcius